Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cronos Group Inc (CRON)

Cronos Group Inc (CRON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,026,421
  • Shares Outstanding, K 380,156
  • Annual Sales, $ 117,620 K
  • Annual Income, $ 41,080 K
  • EBIT $ -19 M
  • EBITDA $ -63 M
  • 60-Month Beta 0.80
  • Price/Sales 7.82
  • Price/Cash Flow 5,737.99
  • Price/Book 0.91

Options Overview Details

View History
  • Implied Volatility 60.89% (-7.22%)
  • Historical Volatility 30.06%
  • IV Percentile 39%
  • IV Rank 18.60%
  • IV High 168.83% on 07/23/25
  • IV Low 36.23% on 07/01/25
  • Expected Move (DTE 28) 0.36 (13.08%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 6,190
  • Volume Avg (30-Day) 1,813
  • Put/Call OI Ratio 0.12
  • Today's Open Interest 144,403
  • Open Int (30-Day) 135,552
  • Expected Range 2.37 to 3.09

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.01
  • Number of Estimates 1
  • High Estimate 0.01
  • Low Estimate 0.01
  • Prior Year -0.01
  • Growth Rate Est. (year over year) +200.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.40 +13.54%
on 02/02/26
2.83 -3.71%
on 01/23/26
+0.17 (+6.86%)
since 01/20/26
3-Month
2.28 +19.52%
on 11/21/25
3.43 -20.55%
on 12/15/25
+0.42 (+18.48%)
since 11/20/25
52-Week
1.60 +70.31%
on 04/09/25
3.43 -20.55%
on 12/15/25
+0.78 (+40.46%)
since 02/20/25

Most Recent Stories

More News
Cronos Launches New All-in-One Vape, Spinach PUFFERZ™

TORONTO, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabinoid company, announced today the launch of its newest all-in-one (AIO)...

CRON : 2.72 (+0.74%)
CRON.TO : 3.73 (+0.27%)
Cronos Group Inc. to Hold 2025 Fourth Quarter and Full-Year Earnings Conference Call on February 26, 2026

TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2025 fourth quarter and full-year earnings conference call on...

CRON : 2.72 (+0.74%)
CRON.TO : 3.73 (+0.27%)
Cronos Group Launches Premium Lord Jones® Brand in Israel, Advancing Borderless Product Strategy

TORONTO, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON; TSX: CRON) (“Cronos” or the “Company”), a leading global cannabinoid company, today announced the launch of its Lord...

CRON : 2.72 (+0.74%)
CRON.TO : 3.73 (+0.27%)
Cronos to enter the Netherlands with acquisition of Europe’s largest adult-use cannabis company

Cronos to acquire CanAdelaar for up-front cash consideration of US$67.0M 1 plus cash earnout of 0.5x normalized EBITDA in 2026 and 2027 Up-front consideration represents approximately 1.4x CanAdelaar...

CRON : 2.72 (+0.74%)
CRON.TO : 3.73 (+0.27%)
Cronos Launches Premium Lord Jones Live Resin Fusions™ in Canada

TORONTO, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced is expanding its...

CRON : 2.72 (+0.74%)
CRON.TO : 3.73 (+0.27%)
Cronos Group Reports 2025 Third Quarter Results

Achieved record levels of consolidated net revenue, gross profit and Adjusted EBITDA Net revenue in Q3 2025 increased by 9% quarter-over-quarter and 6% year-over-year Generated record-high...

CRON : 2.72 (+0.74%)
CRON.TO : 3.73 (+0.27%)
Cronos Brings Back Popular, Limited-Edition Spinach® Green Apple-Flavored Products for the Fall Season

TORONTO, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabinoid company, announced today that it is welcoming back its limited-edition...

CRON : 2.72 (+0.74%)
CRON.TO : 3.73 (+0.27%)
Cronos Group Inc. to Hold 2025 Third Quarter Earnings Conference Call on November 6, 2025

TORONTO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2025 third quarter earnings conference call on Thursday, November...

CRON : 2.72 (+0.74%)
CRON.TO : 3.73 (+0.27%)
Cronos launches SOURZ by Spinach® Fully Blasted Multipacks

TORONTO, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabinoid company, today announced that its popular SOURZ by Spinach ®...

CRON : 2.72 (+0.74%)
CRON.TO : 3.73 (+0.27%)
This 1 Cannabis Dividend Stock Yields 3%

You may not think about Constellation Brands as a marijuana stock, but it still has a huge stake in Canopy Growth.

ACB : 3.76 (+0.27%)
CRON : 2.72 (+0.74%)
TAP : 49.81 (+3.02%)
TLRY : 7.78 (-1.39%)
STZ : 156.56 (+1.24%)
CGC : 1.1900 (+1.71%)
SAM : 234.07 (+1.11%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Cronos Group, Inc. engages in the investment in firms which are licensed to produce and sell medical marijuana. Its portfolio includes In The Zone, Peace Naturals, Whistler Medical Marijuana Co., ABcann, Hydropothecary, Vert Medical and Evergreen Medicinal Supply. Cronos Group Inc., formerly known as...

See More

Key Turning Points

3rd Resistance Point 2.80
2nd Resistance Point 2.76
1st Resistance Point 2.73
Last Price 2.72
1st Support Level 2.66
2nd Support Level 2.62
3rd Support Level 2.59

See More

52-Week High 3.43
Fibonacci 61.8% 2.73
Last Price 2.72
Fibonacci 50% 2.52
Fibonacci 38.2% 2.30
52-Week Low 1.60

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar